Candel Therapeutics shares rose 3.4% after the U.S. Food and Drug Administration provided an orphan drug label for the company's glioma treatment
在美国食品药品管理局为公司的神经胶质瘤治疗提供孤儿药标签后Candel Therapeutics股价上涨3.4％
Candel Therapeutics shares rose 3.4% after the U.S. Food and Drug Administration provided an orphan drug label for the company's glioma treatment
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.